NCT02061085 2025-06-08
MERIBEL
MedSIR
Phase 2 Completed
Clinical Trials
8 trialsNCT02915744 2023-04-14
ATTAIN
Nektar Therapeutics
Phase 3 Completed
NCT01795586 2022-10-31
A Phase I Dose Escalation Study of Eribulin Plus Weekly Carboplatin for Metastatic Breast Patients
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT02551263 2021-06-11
E-SPEC
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Completed
NCT01596751 2020-07-17
Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer
University of California, San Francisco
Phase 1/2 Completed
NCT01961544 2016-10-07
ESKIMO
Eisai Inc.
Phase 4 Completed
NCT00278993 2014-07-14
Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior Chemotherapy
Eisai Inc.
Phase 2 Completed
NCT00069264 2011-12-20
Study of E7389 in Patients With Advanced Solid Tumors
Eisai Inc.
Phase 1 Completed